Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
DXJI9Z
|
||||
| Drug Name |
4-Isopropyl-N-{1-[2-(4-methoxy-phenylamino)-ethylcarbamoyl]-3-methyl-butyl}-benzamide
|
||||
| Synonyms |
CHEMBL306503
|
||||
| Indication | Discovery agent | Investigative | [1587926] | ||
| Formula |
C25H35N3O3
|
||||
| Canonical SMILES |
COc1ccc(NCCNC(=O)[C@H](CC(C)C)NC(=O)c2ccc(cc2)C(C)C)cc1
|
||||
| InChI |
InChI=1S/C25H35N3O3/c1-17(2)16-23(28-24(29)20-8-6-19(7-9-20)18(3)4)25(30)27-15-14-26-21-10-12-22(31-5)13-11-21/h6-13,17-18,23,26H,14-16H2,1-5H3,(H,27,30)(H,28,29)/t23-/m0/s1
|
||||
| InChIKey |
IJTODUASIQRBBU-QHCPKHFHSA-N
|
||||
| Target and Pathway | |||||
| Target(s) | Cathepsin K | Target Info | [1587926] | ||
| Cathepsin L | Target Info | [1587926] | |||
| Reactome | Collagen degradation | ||||
| Degradation of the extracellular matrix | |||||
| Activation of Matrix Metalloproteinases | |||||
| Trafficking and processing of endosomal TLR | |||||
| MHC class II antigen presentationR-HSA-1236977:Endosomal/Vacuolar pathway | |||||
| Assembly of collagen fibrils and other multimeric structures | |||||
| MHC class II antigen presentation | |||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.